Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Companies to Analyze 40,000 Protein Samples

DNAmolcule model

A partnership between genomic analysis company deCode Genetics and proteomics enterprise SomaLogic plans to analyze protein activity in 40,000 human samples. . . . → Read More: Companies to Analyze 40,000 Protein Samples

Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

Editing DNA

A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round. . . . → Read More: Nanotech Gene Therapy Company Raises $8.5M in Seed Funds

RNA Biotech Raises $604M in IPO

NASDAQ share price display

Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO

Report – 289 Cell and Gene Therapies in Development

Human T-cell

A report by a pharmaceutical industry organization says nearly 300 new therapies that transfer live cells or genes as treatments for disease are in clinical trials or being reviewed by Food and Drug Administration. . . . → Read More: Report – 289 Cell and Gene Therapies in Development

Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study

Inspecting lung X-rays

A collaboration of Mount Sinai medical center, drug maker Sanofi, and data science company Sema4 aims to track people with asthma for 5 years to help develop personalized treatments for the disease. . . . → Read More: Mount Sinai, Sanofi, Sema4 Partner on Long-Term Asthma Study

FDA Identifies Database to Evaluate Precision Diagnostics

DNA puzzle

The Food and Drug Administration identified a public database of genomics and diseases as a resource to assess new diagnostics tests using genetic data for precision medicine. . . . → Read More: FDA Identifies Database to Evaluate Precision Diagnostics

Trial Results Show Gene Transfers Reverse Sickle Cell Disease

Gene therapy lab

Results from the first 2 participants in a clinical trial show transferring healthy genes to patients with sickle cell disease reverses symptoms of the disease that continues for up to 1 year. . . . → Read More: Trial Results Show Gene Transfers Reverse Sickle Cell Disease

Trials OK’d for Inherited Eye Disease Therapy with Crispr

Crispr-Cas9 illustration

The company developing a treatment for a rare inherited eye disease using the genome editing technique Crispr received authorization from the Food and Drug Administration to begin clinical trials. . . . → Read More: Trials OK’d for Inherited Eye Disease Therapy with Crispr

Project to Catalog Precision Lung Cancer Immunotherapies

Lung cancer development

A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer. . . . → Read More: Project to Catalog Precision Lung Cancer Immunotherapies

Company Formed to Advance Sickle Cell Gene Therapy

Sickle cell illustration

A Swiss medical technologies company and Cincinnati Children’s hospital in Ohio are starting a new enterprise to commercialize research on gene therapies for inherited blood disorders. . . . → Read More: Company Formed to Advance Sickle Cell Gene Therapy